"Panacea Biotec ensures increased availability of life saving drug Cilamin250 (D-Penicillamine IP 250mg) capsules for treatment of Wilson's disease in India," the company said in a BSE filing.
It further said: "Cilamin250...Wtinessed short supply in the market in the last few months due to non-availability oif raw materials D-Penicillamine in India...We have now impoved supply of Cilamin250 capsules which has been made available in the retail market."